Unbound E2F modulates TGF-β1-induced apoptosis in HuH-7 cells

Journal of Cell Science

Volumn 115, Issue 15, 2002, Pages 3181-3191

  Fan, Guangsheng ^a   Ma, Xiaoming ^a   Kren, Betsy T ^a   Steer, Clifford J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Cytokine; E2F transcription factors; Human hepatoma cells; TGF 1

Indexed keywords

MESSENGER RNA; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F; TRANSFORMING GROWTH FACTOR BETA1; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; TGFB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA BINDING; GENE CONSTRUCT; HEPATOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; CELL CULTURE; CELL CYCLE; DRUG EFFECT; EUKARYOTIC CELL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MACROMOLECULE; METABOLISM; UPREGULATION;

APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELLS, CULTURED; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; EUKARYOTIC CELLS; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; MACROMOLECULAR SUBSTANCES; RETINOBLASTOMA PROTEIN; RNA, MESSENGER; S PHASE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 0036675663     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Ectopic E2F expression induces S phase and apoptosis in Drosophila imaginal discs
2. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-κB transcription factor
3. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A trans-activation
4. DP-1: A cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein
5. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo
6. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo
7. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F
8. Requirement for a functional Rb-1 gene in murine development
9. Loading and transfer control for Northern hybridization
10. Distinct roles for E2F proteins in cell growth control and apoptosis
11. The regulation of E2F by pRB-family proteins
12. Apoptosis and the cell cycle
13. TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
14. Differential regulation of retinoblastoma tumor suppressor protein by G'1 cyclin-dependent kinase complexes in vivo
15. The retinoblastoma gene product is a negative modulator of the apoptotic pathway
16. Modulation of retinoblastoma and retinoblastoma-related proteins in regenerating rat liver and primary hepatocytes
17. The retinoblastoma gene product inhibits TGF-β1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells
18. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product
19. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control
20. E2F4 is exported from the nucleus in a CRM1-dependent manner
21. E2F4, a new member of the E2F transcription factor family, interacts with p107
22. A new component of the transcription factor DRTF1/E2F
23. Inhibition of apoptosis by the retinoblastoma gene product
24. The Rb/E2F pathway: Expanding roles and emerging paradigms
25. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation
26. E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis
27. E2F-5, a new E2F family member that interacts with p130 in vivo
28. E2F-1-induced p53-independent apoptosis in transgenic mice
29. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
30. E2F and histone deacetylase mediate transforming growth factor β repression of cdc25A during keratinocyte cell cycle arrest
31. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis
32. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
33. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression
34. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
35. Transforming growth factor-β1 inhibits cyclin D1 expression in intestinal epithelial cells
36. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members
37. The biochemistry of programmed cell death
38. The retinoblastoma protein binds to a family of E2F transcription factors
39. kip1 by the viral E1A oncoprotein in TGFβ-treated cells
40. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein
41. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry
42. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens
43. Apaf-1 is a transcriptional target for E2F and p53
44. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis
45. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1
46. Functional properties of a Drosophila homolog of the E2F1 gene
47. E2F-dependent regulation of human MYC: Trans-activation by cyclins D1 and A overrides tumour suppressor protein functions
48. Induction of DNA synthesis and apoptosis are separable functions of E2F-1
49. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways
50. E2F and its developmental regulation in Xenopus laevis
51. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis
52. Inhibition of G1 phase cyclin dependent kinases by transforming growth factor β1
53. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β
54. The retinoblastoma protein: More than a tumor suppressor
55. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation
56. Active repression and E2F inhibition by pRB are biochemically distinguishable
57. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle
58. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis
59. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis
60. A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor β-arrested epithelial cells
61. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E
62. Analysis of promoter binding by the E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression
63. Mutation of E2F-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos
64. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase
65. p53 and E2F-1 cooperate to mediate apoptosis
66. In vivo association of E2F and DP family proteins
67. The E2F1-3 transcription factors are essential for cellular proliferation
68. Interaction between the retinoblastoma protein and the oncoprotein MDM2
69. INK4Aa, TGFβ, and contact inhibition
70. E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos